Multidimensional mechanisms of quercetin in diabetic kidney disease
Zhaoyuan Gong, Qianzi Che, Chuxuan Wang, Bin Liu, Mingzhi Hu, Haili Zhang, Ning Liang, Huizhen Li, Guozhen Zhao, Lijiao Yan, Tian Song, Lin Chen, Nannan Shi, Jing Guo
TL;DR
This review explores how quercetin, a flavonoid, may help treat diabetic kidney disease by targeting inflammation, oxidative stress, and cell death.
Contribution
The paper systematically summarizes quercetin's potential as a senolytic drug for diabetic kidney disease through network pharmacology and molecular mechanisms.
Findings
Quercetin may eliminate senescent cells in diabetic kidney disease.
The compound acts on key targets and pathways related to inflammation and oxidative stress.
Quercetin's therapeutic mechanisms are analyzed across three biological dimensions.
Abstract
Quercetin is a flavonoid compound that has demonstrated substantial potential in the treatment of diabetic kidney disease (DKD). However, there is still a lack of systematic research on the exact mechanism of action of quercetin. This review discusses the druggability, molecular targets, and signaling pathways of quercetin in DKD treatment. We retrieved the latest research on the pharmacological effects and mechanisms related to quercetin from PubMed and Scopus as of June 2025 (2012–2025). Evidence suggests that quercetin has the potential to eliminate senescent cells in DKD. Network pharmacology was used to predict the targets and pathways of quercetin in targeting cellular senescence to treat DKD. Using on existing research, it was further confirmed that quercetin can effectively act on hub target and pathway. The mechanism of quercetin therapy in DKD was summarized from three…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTelomeres, Telomerase, and Senescence · Chronic Kidney Disease and Diabetes · Natural Antidiabetic Agents Studies